2023-03-30T16:58:22+08:00 weekly 1.0 https://bg.prisysbiotech.com/ 2023-02-27T15:56:40+08:00 weekly 0.9 https://bg.prisysbiotech.com/co-develop 2024-11-13T14:58:17+08:00 weekly 0.9 https://bg.prisysbiotech.com/animal-welfare 2024-11-13T14:58:12+08:00 weekly 0.9 https://bg.prisysbiotech.com/translational-research-center 2024-11-13T14:58:26+08:00 weekly 0.9 https://bg.prisysbiotech.com/metabolic-syndromes-research 2024-11-13T14:58:21+08:00 weekly 0.9 https://bg.prisysbiotech.com/cns-disorders-behavior-analysis 2024-11-13T14:58:20+08:00 weekly 0.9 https://bg.prisysbiotech.com/inflammation-immunology-disorders 2024-11-13T14:58:22+08:00 weekly 0.9 https://bg.prisysbiotech.com/respiratory-disease-research 2024-11-13T14:58:19+08:00 weekly 0.9 https://bg.prisysbiotech.com/ophthalmic-disease-research 2024-11-13T14:58:17+08:00 weekly 0.9 https://bg.prisysbiotech.com/hematological-disease-research 2024-11-13T14:58:12+08:00 weekly 0.9 https://bg.prisysbiotech.com/download 2024-09-29T14:45:25+08:00 weekly 0.9 https://bg.prisysbiotech.com/nephrology 2024-09-29T14:23:03+08:00 weekly 0.9 https://bg.prisysbiotech.com/fibrosis 2024-11-13T14:58:12+08:00 weekly 0.9 https://bg.prisysbiotech.com/about-us 2024-11-13T14:58:14+08:00 weekly 0.9 https://bg.prisysbiotech.com/contact-us 2023-04-01T02:49:33+08:00 weekly 0.9 https://bg.prisysbiotech.com/newslist-1 2024-11-13T14:58:19+08:00 weekly 0.9 https://bg.prisysbiotech.com/products 2026-02-07T02:37:28+08:00 weekly 0.9 https://bg.prisysbiotech.com/blog/ 2023-04-01T02:49:26+08:00 weekly 1.0 https://bg.prisysbiotech.com/nhp-pharmacology/ 2023-04-01T02:49:27+08:00 weekly 0.9 https://bg.prisysbiotech.com/biosafety-research/ 2023-04-01T02:49:27+08:00 weekly 0.9 https://bg.prisysbiotech.com/safety-evaluation/ 2023-04-01T02:49:27+08:00 weekly 0.9 https://bg.prisysbiotech.com/translation-research/ 2023-04-01T03:04:13+08:00 weekly 0.9 https://bg.prisysbiotech.com/pk-pd-adme/ 2024-04-08T17:30:32+08:00 weekly 0.9 https://bg.prisysbiotech.com/clearpoint/ 2024-11-13T14:58:20+08:00 weekly 0.8 https://bg.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html 2024-11-13T14:58:26+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://bg.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/non-human-primate.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html 2024-11-13T14:58:53+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html 2024-11-13T14:58:23+08:00 weekly 0.8 https://bg.prisysbiotech.com/pk-pd-adme/toxicokinetics.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://bg.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html 2024-11-13T14:58:25+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html 2024-11-13T14:58:24+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html 2024-11-13T14:58:24+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html 2024-11-13T14:58:22+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html 2024-11-13T14:58:25+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://bg.prisysbiotech.com/translation-research/translational-studies.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html 2024-11-13T14:58:35+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://bg.prisysbiotech.com/safety-evaluation/toxicology.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html 2024-11-13T14:58:20+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html 2024-11-13T14:58:26+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html 2024-11-13T14:58:21+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html 2024-11-13T14:58:19+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://bg.prisysbiotech.com/safety-evaluation/immunotoxicity.html 2024-11-13T14:58:23+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html 2024-11-13T14:58:25+08:00 weekly 0.8 https://bg.prisysbiotech.com/biosafety-research/biosafetyresearch.html 2024-11-13T14:58:31+08:00 weekly 0.8 https://bg.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html 2023-04-01T03:18:43+08:00 weekly 0.8 https://bg.prisysbiotech.com/pk-pd-adme/adme.html 2024-11-13T14:58:21+08:00 weekly 0.8 https://bg.prisysbiotech.com/translation-research/nhpresources.html 2024-11-13T14:58:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html 2024-11-13T14:58:39+08:00 weekly 0.8 https://bg.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html 2024-11-13T14:58:49+08:00 weekly 0.8 https://bg.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html 2024-11-13T14:58:28+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html 2024-11-13T14:58:40+08:00 weekly 0.8 https://bg.prisysbiotech.com/translation-research/clinical-imaging.html 2024-09-27T04:44:12+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html 2024-09-27T04:44:16+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html 2024-09-27T04:44:17+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html 2024-09-27T04:44:18+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html 2024-11-13T14:58:30+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html 2024-09-27T04:44:42+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html 2024-09-27T04:44:59+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html 2024-12-07T17:54:17+08:00 weekly 0.8 https://bg.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html 2024-12-07T19:17:11+08:00 weekly 0.8 https://bg.prisysbiotech.com/clearpoint/nhp-neuroscience.html 2025-04-05T23:10:49+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html 2025-04-05T23:39:34+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html 2025-07-18T00:43:48+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html 2025-07-18T00:43:57+08:00 weekly 0.8 https://bg.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html 2025-08-20T21:18:55+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html 2025-09-14T11:06:14+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html 2025-09-20T08:36:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html 2025-09-25T01:59:47+08:00 weekly 0.8 https://bg.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html 2025-10-01T13:37:37+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html 2025-12-25T18:48:03+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html 2026-01-29T19:28:56+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html 2026-05-04T02:28:15+08:00 weekly 0.8 https://bg.prisysbiotech.com/translation-research/dsa-guided-interventional-platform.html 2026-05-04T02:28:31+08:00 weekly 0.8 https://bg.prisysbiotech.com/pk-pd-adme/nhp-intracerebral-injection-icm-services.html 2026-05-04T02:28:21+08:00 weekly 0.8 https://bg.prisysbiotech.com/translation-research/biodistribution-imaging-service.html 2026-05-04T02:28:35+08:00 weekly 0.8 https://bg.prisysbiotech.com/pk-pd-adme/nhp-intrathecal-dosing-csf-sampling.html 2026-05-25T20:13:40+08:00 weekly 0.8 https://bg.prisysbiotech.com/pk-pd-adme/nhp-intracerebroventricular-icv-injection.html 2026-05-25T20:13:37+08:00 weekly 0.8 https://bg.prisysbiotech.com/nhp-pharmacology/nhp-focal-segmental-glomerulosclerosis-fsgs.html 2023-04-01T02:49:25+08:00 weekly 0.9 https://bg.prisysbiotech.com/newslist-714174-1 2023-04-01T02:49:26+08:00 weekly 0.9 https://bg.prisysbiotech.com/newslist-714175-1 2024-07-30T05:58:30+08:00 weekly 0.9 https://bg.prisysbiotech.com/newslist-818855-1 2026-05-04T02:15:55+08:00 weekly 0.9 https://bg.prisysbiotech.com/newslist-17857632552461312-1 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/meetprisys-sot2023-66123464.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66123466.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66123467.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/prisys-sot2023-66123468.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66123469.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/gene-therapy-nhp-model-66123470.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66123471.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66123472.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66123473.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66123478.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/gene-therapy-toxicology-66275405.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67535000.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67535001.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67536018.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67536019.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/world-parkinsons-disease-day-67536550.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67538859.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67539654.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67543308.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68111974.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68111975.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68111988.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68112845.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68321257.html 2023-07-09T07:52:35+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69076038.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69076042.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69076400.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69076574.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69077049.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69077052.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309268.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309323.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309380.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309395.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69658516.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69659547.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-70974607.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-70974609.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-70974610.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-70974611.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-70974612.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/0-70974613.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72321800.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72321801.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72321802.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72321803.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72321804.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72677983.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73016140.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73540891.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73541650.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74254582.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74657717.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74793790.html 2024-11-13T14:58:10+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75165124.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75165133.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76179739.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77060135.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77710199.html 2024-11-13T14:58:10+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77710200.html 2024-11-13T14:58:15+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79198369.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79198370.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/nhp-asthma-model-79198371.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79198372.html 2024-11-13T14:58:14+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79198373.html 2024-11-13T14:58:17+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79421989.html 2024-11-13T14:58:23+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79421990.html 2024-11-13T14:58:13+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79421991.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79537466.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79537468.html 2024-11-13T14:58:14+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79537469.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79537470.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79537471.html 2024-11-13T14:58:20+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79537472.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79537473.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79537475.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79537476.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79537479.html 2024-11-13T14:58:21+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79537480.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79537481.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79537482.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79537483.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79537484.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79537485.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79537486.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79537487.html 2024-11-13T14:58:14+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79537488.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79537489.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79537490.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79537491.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79537492.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79537494.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79537495.html 2024-11-13T14:58:15+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79537496.html 2024-11-13T14:58:22+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79537497.html 2024-11-13T14:58:16+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/mrna-based-therapies-past-79537498.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79537499.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79537500.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79537501.html 2024-11-13T14:58:17+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/pk-strategies-of-pdc-79537502.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79537503.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79537504.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79537505.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/mrna-based-therapies-present-79537506.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79537507.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79537508.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79537509.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/significance-principles-and-requirements-of-79537510.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79537511.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79537512.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79538586.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79538587.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79538588.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79538590.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79540811.html 2024-08-07T08:44:37+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656493.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81140329.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81140330.html 2024-11-13T14:58:18+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/convection-enhanced-delivery-81140331.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/china-experimental-monkey-industry-81140332.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81140333.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/human-disease-animal-models-81140334.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/animal-models-of-human-diseases-81140335.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81140336.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81140337.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81140339.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81140340.html 2024-11-13T14:58:19+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81140341.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/compartment-pk-model-81140344.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82395260.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82711903.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82711904.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82711905.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82711906.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82711909.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82711910.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82711911.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82711912.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82711913.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83016894.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83017703.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83023420.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-84029112.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-84029113.html 2025-01-20T20:07:40+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-84029114.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-84029115.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-84029116.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-84029117.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-84029126.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-84029128.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-84029146.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17245514843546624.html 2025-02-27T10:08:20+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17245515144930304.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17301140956947456.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17301140974232576.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17301140994073600.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17301141055546368.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17301141081170944.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/membranous-nephropathy-model-17301141084414976.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/animal-models-for-womens-health-17301141143774208.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17301141147755520.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17301141181522944.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17301141232903168.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17301141248500736.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17301141251679232.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17301141322458112.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17301141331207168.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17301141354832896.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17301141443683328.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/liver-biopsy-a-crucial-technique-in-large-ani-17301141564384256.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17302058912850944.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17385249238262784.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17385249282024448.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17385249299653632.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17385249320150016.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/intracerebroventricular-icv-injection-17385249391617024.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17385249591878656.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17385249729111040.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17385250586944512.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17386387267281920.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17386387300443136.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17386387464938496.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17386388589700096.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17447036996051968.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17447037074875392.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17447037086688256.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/key-considerations-for-dosing-volume-17447037198787584.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17447037226230784.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17447037403866112.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17447037405422592.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17447037500515328.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17447037941261312.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17447038549861376.html 2025-07-18T01:57:16+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17447074636407808.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17447074703254528.html 2025-08-20T21:18:45+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17494938464166912.html 2025-08-20T21:18:44+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17494938473686016.html 2025-08-20T21:18:45+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17494938522821632.html 2025-08-20T21:18:51+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17494938548020224.html 2025-08-20T21:18:41+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17494938701095936.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/nhp-copd-model-17494965071422464.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/brain-targeted-drug-delivery-17529752294990848.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17529752364573696.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17529752450376704.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17529752486487040.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17529752490501120.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/the-importance-of-administration-volume-17529752555529216.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17529752567292928.html 2025-09-20T08:36:38+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17538076523783168.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17553966565762048.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17625030700590080.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17625030701704192.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17625030732129280.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17625030858417152.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17625030859105280.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17625030964782080.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/nhp-renal-biopsy-17625030982099968.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/rfp-template-for-nhp-studies-17625031337731072.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17625031664329728.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17625031780148224.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17625031882466304.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674595231179776.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674595364856832.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674595382338560.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674595406717952.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674595502679040.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674595521340416.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674595537183744.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674595571295232.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674595652314112.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724180604789760.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724180650501120.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724180741153792.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724180755948544.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724180804707328.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724180906812416.html 2026-01-29T19:50:41+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724189053330432.html 2026-01-29T19:50:47+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724189179929600.html 2026-01-29T19:50:58+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724189212664832.html 2026-01-29T19:50:50+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724189361841152.html 2026-05-04T02:16:16+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/ipf-drug-development-nhp-ct-imaging-pft-17857632630498304.html 2026-05-04T02:16:12+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/nhp-cns-biodistribution-studies-intrathecal-17857632633676800.html 2026-05-04T02:16:00+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/ai-markerless-nhp-3d-behavior-analysis-system-17857632641082368.html 2026-05-04T02:16:18+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/translational-pk-pd-framework-cynomolgus-17857632693462016.html 2026-05-04T02:16:10+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/mri-guided-cns-delivery-in-nhp-models-17857632811279360.html 2026-05-04T02:16:05+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/evaluating-dmpk-properties-17857632961307648.html 2026-05-04T02:17:52+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/drug-development-reliance-on-nhp-models-17857634265900032.html 2026-05-04T02:28:33+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/pet-ct-biodistribution-in-nhp-models-for-cns-17857645114582016.html 2026-05-04T02:28:14+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-antibody-safety-17857645198582784.html 2026-05-04T02:28:13+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/non-glp-pharmacology-data-integrity-17857645221061632.html 2026-05-04T02:28:47+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/in-vivo-immune-cell-tracking-17857645231760384.html 2026-05-04T02:28:13+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/dopamine-transporter-pet-imaging-in-nhp-models-17857645234758656.html 2026-05-04T02:28:11+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/large-animal-radiolabeling-and-in-vivo-imaging-17857645251994624.html 2026-05-04T02:28:49+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/prisys-supports-ind-approval-of-ux-gip001-17857645294593024.html 2026-05-04T02:28:12+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/nonlinear-pharmacokinetics-nhp-pkpd-17857645365322752.html 2026-05-29T18:49:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/nonclinical-pharmacokinetics-strategy-17857657478292480.html 2026-05-25T20:13:37+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/on-demand-webinar-mri-ced-nhp-17888419203048448.html 2026-05-25T20:13:34+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/nhp-models-translational-drug-development-17888419209012224.html 2026-05-25T20:13:36+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/pk-data-as-translational-biomarker-17888419263800320.html 2026-05-25T20:13:44+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/non-human-primate-models-of-pulmonary-fibrosis-17888419276612608.html 2026-05-25T20:14:24+08:00 weekly 0.8 https://bg.prisysbiotech.com/news/pk-data-as-pharmacodynamic-biomarker-17888419876381696.html 2026-02-06T06:16:55+08:00 weekly 0.8 https://bg.prisysbiotech.com/blog/how-do-nhp-preclinical-studies-help-in-the-development-of-geriatric-drugs-2844578.html 2026-02-12T04:51:27+08:00 weekly 0.8 https://bg.prisysbiotech.com/blog/how-are-nhps-selected-for-a-study-2921463.html 2026-02-27T06:19:51+08:00 weekly 0.8 https://bg.prisysbiotech.com/blog/what-are-the-advantages-of-using-an-nhp-cro-3016066.html 2026-03-03T06:29:07+08:00 weekly 0.8 https://bg.prisysbiotech.com/blog/what-is-the-pharmacokinetic-profile-of-inhaled-drugs-3053038.html 2026-03-10T06:10:54+08:00 weekly 0.8 https://bg.prisysbiotech.com/blog/how-do-pd-drugs-influence-the-immune-cells-in-the-brain-in-pharmacology-3122306.html 2026-03-24T05:34:31+08:00 weekly 0.8 https://bg.prisysbiotech.com/blog/how-to-measure-the-infarct-volume-in-the-mcao-nhp-model-3321686.html 2026-04-24T07:01:49+08:00 weekly 0.8 https://bg.prisysbiotech.com/blog/pk-pd-clinical-implications-3748810.html 2026-05-18T04:52:20+08:00 weekly 0.8 https://bg.prisysbiotech.com/blog/nhp-preclinical-studies-drug-development-significance-4028209.html